We demonstrated that HHcy potentiated hyperglycemia-induced ED via μ-calpain/PKCβ2 activation-mediated eNOS-pThr49, eNOS inactivation and NO reduction [15]. The gene discussed is CAPN2; the disease is Hyperglycemia.